 recent advanc antagonist treatment second-gener antagonist terfenadin astemizol loratadin cetirizin import first-lin drug relief symptom patient allerg rhinoconjunct chronic urticaria sedat first-gener antagonist treatment disord terfenadin astemizol loratadin cetirizin incid central nervou system anticholinerg advers effect similar placebo abil antagonist recent pharmacokinet pharmacodynam studi medic